I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)
A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.
progranulin
dementia
pick's disease
aphasia
- 0 views
- 19 Feb, 2024